drugset / Trial / NCT02004067

Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

NCT02004067

Phase 4 Completed 100 enrolled Federal University of São Paulo Allergan · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

In the present study the investigators aim to determine the efficacy of an immunomodulating topical medication, compared with a topical lubricant, on the treatment of dry eye disease (DED) due to primary or secondary Sjögren's syndrome (aqueous deficient DED) and evaporative DED.

Timeline

Start
2013-01
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Castor Oil Unknown Topical
Subject Cyclosporine Peptide 0.5 mg/ml Topical